AngioDynamics Inc. (ANGO) reported a narrower loss for the fourth quarter compared to the previous year, surpassing Wall Street expectations.
The company posted a net loss of $13.449 million, or $0.33 per share, for the fourth quarter. This is an improvement from the net loss of $21.467 million, or $0.54 per share, recorded in the same period last year.
On an adjusted basis, excluding special items, AngioDynamics reported a loss of $2.251 million or $0.06 per share for the quarter. This performance exceeded analysts' average forecast of a loss of $0.16 per share, based on figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
Revenue for the quarter declined by 22.1% to $70.980 million, compared to $91.074 million in the previous year.
Summary of AngioDynamics Inc.'s GAAP quarterly performance:
- Earnings (Q4): -$13.449 million vs. -$21.467 million last year
- EPS (Q4): -$0.33 vs. -$0.54 last year
- Revenue (Q4): $70.980 million vs. $91.074 million last year
